Transmedics Group P/E 2024

Transmedics Group Aktienanalyse

What does Transmedics Group do?

Transmedics Group Inc is a company dedicated to the development and manufacturing of medical devices for organ transplantation. The company was founded in 1998 and is headquartered in Andover, Massachusetts, USA. Transmedics' business model is based on offering a unique and innovative technology for organ preservation during transport from donor to recipient. The patented Organ Care System (OCS) platform includes a range of state-of-the-art medical devices specifically designed for organ transport. Transmedics' Organ Care System includes three main devices: OCS Heart, OCS Lung, and OCS Liver. Each device is tailored for organ preparation and transport, providing individualized support based on the specific requirements of each organ and different transfer protocols. The OCS technology uses hypothermic (cold) perfusion to preserve the organ during transport. By continuously monitoring and supporting the organ's physiological functions, the OCS system can improve the survival rate of donor organs while reducing the time spent outside the body. Transmedics also offers comprehensive services, including the availability of OCS devices and qualified personnel to provide support throughout the transplantation process. Transmedics' customers include leading transplant centers and hospitals worldwide. The company works closely with these customers to ensure that its OCS devices meet the specific requirements of each transplantation program and help them achieve more successful transplantations. Transmedics' history is marked by a passion for improving transplantation medicine and saving lives through the provision of advanced technologies and solutions. The company has made significant progress in recent years and has experienced strong growth in all areas. Transmedics has also received a number of awards and recognition for its commitment to improving transplantation medicine. For example, in 2020, the company received the Red Herring Top 100 Global Award and was recognized for the seventh consecutive year as one of the fastest-growing companies by Deloitte. Overall, Transmedics is a leading provider of innovative medical devices for transplantation medicine. Through its organic technology and comprehensive service, the company supports transplant centers and hospitals worldwide in performing more successful transplantations and saving patients' lives. Transmedics Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Transmedics Group's P/E Ratio

The Price to Earnings (P/E) Ratio of Transmedics Group is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Transmedics Group's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Transmedics Group is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Transmedics Group’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Transmedics Group Stock

What is the price-to-earnings ratio of Transmedics Group?

The price-earnings ratio of Transmedics Group is currently 161.41.

How has the price-earnings ratio of Transmedics Group changed compared to last year?

The price-to-earnings ratio of Transmedics Group has increased by -272.01% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Transmedics Group high compared to other companies?

Yes, the price-to-earnings ratio of Transmedics Group is high compared to other companies.

How does an increase in the price-earnings ratio of Transmedics Group affect the company?

An increase in the price-earnings ratio of Transmedics Group would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Transmedics Group affect the company?

A decrease in the price-earnings ratio of Transmedics Group would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Transmedics Group?

Some factors that influence the price-earnings ratio of Transmedics Group are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Transmedics Group pay?

Over the past 12 months, Transmedics Group paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Transmedics Group is expected to pay a dividend of 0 USD.

What is the dividend yield of Transmedics Group?

The current dividend yield of Transmedics Group is .

When does Transmedics Group pay dividends?

Transmedics Group pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Transmedics Group?

Transmedics Group paid dividends every year for the past 0 years.

What is the dividend of Transmedics Group?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Transmedics Group located?

Transmedics Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Transmedics Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Transmedics Group from 6/15/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/15/2024.

When did Transmedics Group pay the last dividend?

The last dividend was paid out on 6/15/2024.

What was the dividend of Transmedics Group in the year 2023?

In the year 2023, Transmedics Group distributed 0 USD as dividends.

In which currency does Transmedics Group pay out the dividend?

The dividends of Transmedics Group are distributed in USD.